Related Experiment Videos
Melatonin is protective against MPTP-induced striatal and hippocampal lesions
D Acuña-Castroviejo1, A Coto-Montes, M Gaia Monti
1Instituto de Biotecnologia, Universidad de Granada, Spain.
Abstract:
The in vivo effect of melatonin on MPTP-induced neurotoxicity in mouse brain was studied. Melatonin (10 mg/kg) or saline was administered intraperitoneally (i.p.) to mice 30 min prior to a s.c. injection of MPTP (20 mg/kg). After MPTP treatment, the animals received melatonin or saline injections every hour for three hours. Mice were killed 4 hours after the MPTP injection. Regionally-specific increases in lipid peroxidation were observed in corpus striatum and hippocampus (71% and 58%, respectively), but not in cerebral cortex, cerebellum or midbrain. Treatment with melatonin completely reversed the rises in lipid peroxidation products. MPTP-treated mice showed a significant decrease in the striatal tyrosine hydroxylase immunoreactive nerve terminals, an effect that was also prevented by melatonin. These data show that melatonin is neuroprotective in this MPTP model of Parkinson's disease and suggest that melatonin, an endogenous antioxidant and nontoxic compound, may have potential beneficial effects for this neurodegenerative disorder.
Insights
Melatonin protects against MPTP-induced neurotoxicity by reducing lipid peroxidation and preserving dopamine-producing neurons in mice. This suggests melatonin
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Parkinson's disease is a neurodegenerative disorder.
- MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a neurotoxin used to model Parkinson's disease.
- Oxidative stress plays a role in neurodegeneration.
Purpose of the Study:
- To investigate the neuroprotective effects of melatonin against MPTP-induced neurotoxicity in a mouse model.
- To assess the impact of melatonin on oxidative stress markers and dopaminergic neuron integrity.
Main Methods:
- Mice were treated with MPTP (20 mg/kg) or saline.
- Melatonin (10 mg/kg) was administered before and after MPTP injection.
- Lipid peroxidation levels and tyrosine hydroxylase immunoreactivity were measured in specific brain regions.
Main Results:
- MPTP induced significant lipid peroxidation in the corpus striatum and hippocampus.
- Melatonin treatment completely reversed the increase in lipid peroxidation.
- MPTP caused a decrease in striatal tyrosine hydroxylase, which was prevented by melatonin.
Conclusions:
- Melatonin demonstrates neuroprotective effects in the MPTP mouse model of Parkinson's disease.
- Melatonin's antioxidant properties may contribute to its protective effects.
- Melatonin shows potential as a therapeutic agent for neurodegenerative disorders like Parkinson's disease.